S. Rietbrock

First name
S.
Last name
Rietbrock
Freedman, B., Martinez, C., Katholing, A., & Rietbrock, S. (2016). Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation. JAMA Cardiol. http://doi.org/10.1001/jamacardio.2016.0393
Cohen, A. T., Katholing, A., Rietbrock, S., Bamber, L., & Martinez, C. (2017). Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost. http://doi.org/10.1160/th15-08-0686
Martinez, C., Katholing, A., Folkerts, K., & Rietbrock, S. (2018). Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study. Curr Med Res Opin. http://doi.org/10.1080/03007995.2018.1481375
Cairns, V., Wallenhorst, C., Rietbrock, S., & Martinez, C. (2019). Incidence of Lyme disease in the UK: a population-based cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2018-025916
Martinez, C., Wallenhorst, C., Rietbrock, S., & Freedman, B. (2020). Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.014376